Company: DARE
Filing Date: 2025-04-24
Form Type: DEF 14A
Source: 0001401914-25-000014
Chunk: 42

Company: Dare Bioscience, Inc.
Filing Date: 2025-04-24
Form: DEF 14A
Chunk 42
---
 |                      |   2,526 |          |
| Add (Deduct):Year over Year Change in Fair Value of Equity Awards Granted in Prior FY that Vested in the FY                                  |     |      |   33,180 |          |     |                      |   6,419 |          |
| Deduct: Fair Value at the End of the Prior FY of Equity Awards that Failed to Meet Vesting Conditions in the FY                              |     |      |        — |          |     |                      | -16,011 |          |
| Compensation Actually Paid (as defined by SEC rule)                                                                                          |     |      |          | $754,030 |     |                      |         | $414,748 |
| *The amounts reflect the aggregate grant-date fair value reported in the "Option Awards" column in the SCT for the applicable year.          |     |      |          |          |     |                      |         |          |

(3) The amounts reported in column (d) represent the average of the amounts reported for our Non-PEO NEOs as a group in the “Total” column of the SCT in each applicable year. Our Non-PEO NEOs for purposes of calculating the average amounts for 2024 are MarDee Haring-Layton and Lisa Walters-Hoffert, and for 2023 and 2022 are Lisa Walters-Hoffert, our former Chief Financial Officer, and John Fair, our former Chief Commercial Officer.

(4) The amounts reported in column (f) reflect the cumulative total shareholder return (“TSR”) of our common stock for the measurement periods beginning on December 31, 2022 and ending on December 31 2024 are MarDee Haring-Layton and Lisa Walters-Hoffert, respectively, and for 2023 and 2022 are Lisa Walters-Hoffert and John Fair, calculated in accordance with Item 201(e) of Regulation S-K.

(5) The amounts reported in column (g) represent net income (loss) reflected in our audited financial statements for the applicable FY.

Required Disclosure of the Relationship Between CAP and TSR and Net Income

As required by Item 402(v) of Regulation S-K, we are providing the following graphs to illustrate the relationship between the pay and performance figures that are included in the pay versus performance tabular disclosure above. As noted above, CAP for purposes of the tabular disclosure and the following graphs were calculated in accordance with SEC rules and do not fully represent the